1. Home
  2. CELU vs BTCM Comparison

CELU vs BTCM Comparison

Compare CELU & BTCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • BTCM
  • Stock Information
  • Founded
  • CELU 2016
  • BTCM 2001
  • Country
  • CELU United States
  • BTCM United States
  • Employees
  • CELU N/A
  • BTCM N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • BTCM EDP Services
  • Sector
  • CELU Health Care
  • BTCM Technology
  • Exchange
  • CELU Nasdaq
  • BTCM Nasdaq
  • Market Cap
  • CELU 42.2M
  • BTCM 47.8M
  • IPO Year
  • CELU N/A
  • BTCM 2013
  • Fundamental
  • Price
  • CELU $3.24
  • BTCM $2.61
  • Analyst Decision
  • CELU
  • BTCM Hold
  • Analyst Count
  • CELU 0
  • BTCM 1
  • Target Price
  • CELU N/A
  • BTCM N/A
  • AVG Volume (30 Days)
  • CELU 586.5K
  • BTCM 1.9M
  • Earning Date
  • CELU 05-08-2025
  • BTCM 08-19-2025
  • Dividend Yield
  • CELU N/A
  • BTCM N/A
  • EPS Growth
  • CELU N/A
  • BTCM N/A
  • EPS
  • CELU N/A
  • BTCM 0.62
  • Revenue
  • CELU $54,220,000.00
  • BTCM $32,921,999.00
  • Revenue This Year
  • CELU $23.29
  • BTCM $14.32
  • Revenue Next Year
  • CELU N/A
  • BTCM N/A
  • P/E Ratio
  • CELU N/A
  • BTCM $3.86
  • Revenue Growth
  • CELU 138.11
  • BTCM N/A
  • 52 Week Low
  • CELU $1.00
  • BTCM $1.22
  • 52 Week High
  • CELU $5.22
  • BTCM $8.07
  • Technical
  • Relative Strength Index (RSI)
  • CELU 59.84
  • BTCM 45.24
  • Support Level
  • CELU $3.16
  • BTCM $2.30
  • Resistance Level
  • CELU $3.40
  • BTCM $2.93
  • Average True Range (ATR)
  • CELU 0.34
  • BTCM 0.28
  • MACD
  • CELU -0.03
  • BTCM -0.10
  • Stochastic Oscillator
  • CELU 20.71
  • BTCM 20.53

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About BTCM BIT Mining Limited ADS

BIT Mining Ltd is a cryptocurrency mining company, with a long-term plan to encompass the whole cryptocurrency value chain. Its business covers cryptocurrency mining, mining pool, data center operation and mining machine manufacturing. The company has a related and growing deployed Bitcoin mining machine capacity, owns three hydroelectric cryptocurrency mines with combined power capacity of 435MW and the entire mining pool business operated under BTC.com, including the domain name and wallet. It has also entered into a definitive agreement to acquire a 7 nanometer cryptocurrency mining machine manufacturer "Bee Computing", completing its vertical integration, making self-sufficient while also strengthening competitive position.

Share on Social Networks: